These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1873942)

  • 1. Uric acid calculus in renal transplant patients treated with cyclosporine.
    Cantarell MC; Capdevila L; Morlans M; Piera L
    Clin Nephrol; 1991 Jun; 35(6):288. PubMed ID: 1873942
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine A-related proximal tubular dysfunction: impaired handling of uric acid.
    Versluis DJ; Wenting GJ; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4029-30. PubMed ID: 3313991
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 6. The incidence of Kaposi sarcoma in renal transplant patients and its relation to immunosuppression.
    Shmueli D; Shapira Z; Yussim A; Nakache R; Ram Z; Shaharabani E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3209-10. PubMed ID: 2650454
    [No Abstract]   [Full Text] [Related]  

  • 7. Safe conversion from cyclosporine.
    Adams PL; Burkart JM; Hamilton RW; Lorentz WB; Browning MC; Meredith JH; Heise ER
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2010-1. PubMed ID: 3274464
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 10. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of cyclosporine treatment in renal transplantation.
    Tilney NL; Milford EL; Carpenter CB; Lazarus JM; Strom TB; Kirkman RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):179-85. PubMed ID: 3083548
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
    Pomer S; Daniel V; Dreikorn K; Röhl L
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine.
    Sheil AG; Flavel S; Disney AP; Mathew TH; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2214-6. PubMed ID: 3274496
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
    Tolkoff-Rubin NE; Rubin RH
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological and functional findings in renal transplant recipients on cyclosporine and azathioprine treatment.
    Backman U; Bohman SO; Johansson G; Lindgren PG; Wahlberg J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1639-40. PubMed ID: 3079029
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Wegener's granulomatosis after renal transplantation: is cyclosporine the preferred treatment?
    Clarke AE; Bitton A; Eappen R; Danoff DS; Esdaile JM
    Transplantation; 1990 Dec; 50(6):1047-51. PubMed ID: 2256145
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine-associated renal arteriopathy.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
    [No Abstract]   [Full Text] [Related]  

  • 20. Five-year follow-up of graft function and urinary protein excretion in kidney transplant patients immunosuppressed with cyclosporine or azathioprine.
    Widstam-Attorps U; Bergström J; Lefvert AK
    Transplant Proc; 1990 Feb; 22(1):216. PubMed ID: 2309319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.